Skip to main navigation
Biohaven Pharmaceutucals Biohaven Pharmaceutucals
  • About
    • Overview
    • Our People
      • Meet our CEO
    • Board of Directors
    • Scientific Advisory Board
    • Global Collaboration
  • Innovation
    • Pipeline
    • Innovation Engine
    • Clinical Trials at Biohaven
    • Publications
  • Media
    • Top News
    • In The News
    • Media Resources
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
      • Upcoming and Recent Events
    • Financial Filings
      • SEC Filings
    • Stock Information
      • Stock Quote & Chart
      • Historical Lookup
    • Corporate Governance
      • Governance Documents
      • Committees
    • Contact
  • Commitment
    • Overview
    • Early Access Program
  • Careers
    • Overview
    • #BeBiohaven
  • Contact
Search
  • About
    • Overview
    • Our People
      • Meet our CEO
    • Board of Directors
    • Scientific Advisory Board
    • Global Collaboration
  • Innovation
    • Pipeline
    • Innovation Engine
    • Clinical Trials at Biohaven
    • Publications
  • Media
    • Top News
    • In The News
    • Media Resources
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
      • Upcoming and Recent Events
    • Financial Filings
      • SEC Filings
    • Stock Information
      • Stock Quote & Chart
      • Historical Lookup
    • Corporate Governance
      • Governance Documents
      • Committees
    • Contact
  • Commitment
    • Overview
    • Early Access Program
  • Careers
    • Overview
    • #BeBiohaven
  • Contact
Gaurav Munj 2022-03-04T06:42:16+00:00

SEC Filing Details

Site - Investor Relations Nav

  • Overview
  • Press Releases
  • Events and Presentations
  • Financial Filings
  • Stock Information
  • Corporate Governance
  • Contact
    • Upcoming and Recent Events
    • Corporate Presentation
    • SEC Filings
    • Stock Quote & Chart
    • Historical Lookup
    • Governance Documents
    • Committees

SEC Filing Details

Document Details

Form
10-Q
Filing Date
Aug 11, 2025
Document Date
Jun 30, 2025
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Biohaven, Ltd.
Issuer
BIOHAVEN LTD.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

BIOHAVEN (BHVN)

Volume
Market Cap
52 Week High
52 Week Low

Minimum 15 minutes delayed. Source: LSEG

Biohaven white logo

Footer Links - Column 1

  • About
    • Overview
    • Our People
    • Board of Directors
    • Scientific Advisory Board
    • Global Collaboration

Footer Links - Column 2

  • Media
    • Top News
    • In The News
    • Media Resources
  • COMMITMENT
    • Overview
    • Early Access Programs

Footer Links - Column 3

  • Innovation
    • Pipeline
    • Innovation Engine
    • Clinical Trials at Biohaven
    • Publications
  • CAREERS
    • Overview
    • #BeBiohaven
  • CONTACT

Footer Mobile Links

  • About
  • Pipeline
  • Media
  • Investors
  • Commitment
  • Careers
  • Contact

Footer Links - Column 4

  • INVESTORS
    • Overview
    • Press Releases
    • Events and Presentations
    • Financial Filings
    • Stock Information
    • Corporate Governance
    • Contact

BHVN


LISTED


NYSE

Site - Social Media

BIOHAVEN, LTD.

©2026 Biohaven, Ltd.

  • TERMS & CONDITIONS
  • PRIVACY
  • SOCIAL
  • COOKIES